(S)-(+)-Epichlorohydrin CAS 67843-74-7 Assay ≥99.5% ee ≥99.5% High Purity
Ubonelelo lwabavelisi ngoBusulungekileyo obuPhezulu kunye noMgangatho oZinzileyo
I-Epichlorohydrin CAS 106-89-8
(R)-(-)-Epichlorohydrin CAS 51594-55-9
(S)-(+)-Epichlorohydrin CAS 67843-74-7
IiCompounds zeChiral, uMgangatho oPhezulu, iMveliso yoRhwebo
Igama leMchiza | (S)-(+)-Epichlorohydrin |
Izithethantonye | (S)-Epichlorohydrin;(S)-(+)-2-(Chloromethyl)oxirane;(S)-Chloromethyloxirane;(S)-3-Chloropropylene oxide;(S) -1-Chloro-2,3-epoxypropane |
Inombolo yeCAS | 67843-74-7 |
Inombolo yeCAT | RF-CC203 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | C3H5ClO |
Ubunzima beMolekyuli | 92.52 |
Ukuxinana | 1.180 g/mL ku-20℃ (lit.) |
Indawo yokubilisa | 112℃ |
Indawo yokuflasha | 31℃ |
Refractive Index | 1.44 |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | AbunaMbala ukuya kuLulwelo oluMthubi |
Indlela yoVavanyo / yoHlahlelo | ≥99.5% (GC) |
Ukugqithiswa kwe-Enantiomeric | Ewe ≥99.5% |
Ukufuma (KF) | ≤0.30% |
Chroma (Pt-Co) Hazen | ≤30 |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | IiCompounds zeChiral;AbaPhakathi bamayeza |
(S)-Epichlorohydrin (CAS: 67843-74-7) Indlela yokwenziwa
Iphakheji: Ibhotile, umgqomo, 25kg / umphanda, okanye ngokwemfuno umthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi we- (S)-(+)-Epichlorohydrin (CAS: 67843-74-7) enomgangatho ophezulu, yeye-pharmaceutical intermediate kwaye ingasetyenziselwa ukudibanisa i-chiral intermediates kunye neziyobisi ze-chiral.
I-Shanghai Ruifu Chemical Co., Ltd. idlala indima ebalulekileyo kwi-chemistry ye-chiral, inkampani izinikele ekuveliseni i-chiral compounds.Iimveliso zethu zinconywa ngokubanzi ngabathengi.
(S) - (+) -Epichlorohydrin (CAS: 67843-74-7) yibhloko yokwakha i-chiral, esetyenziswe kwi-synthesis ye-Macquarimicins kunye ne-synthesis ye-macrolide RK-397.Ibhloko yokwakha i-Chiral kwi-enantioselective syntheses ye-hydroxyisoxazolidines kunye (+) -cis-sylvaticin, i-agent enokuthi i-antitumor.Isetyenziselwa ukwenza ii-inhibitors ze-fatty acid oxidation njengeemodyuli ezinokubakho ze-metabolic.